Nova Patents
AT411385T

Apo-2 ligand

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

24 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
788698United States of AmericaA
6053398United States of AmericaA

Members24

Family members, oldest first
DocumentOfficeKind
CA2318029A1CanadaA1
WO9936535A1World Intellectual Property Organization (WIPO)A1
AU2325199AAustraliaA
WO9936535A9World Intellectual Property Organization (WIPO)A9
US6046048AUnited States of AmericaA
EP1045906A1European Patent Office (EPO)A1
HK1032603A1Hong Kong, ChinaA1
JP2002508962AJapanA
US6740739B1United States of AmericaB1
US2005089958A1United States of AmericaA1
US2008176788A1United States of AmericaA1
AT411385TThis recordAustriaT
EP1045906B1European Patent Office (EPO)B1
DE69939732D1GermanyD1
EP2017341A2European Patent Office (EPO)A2
PT1045906EPortugalE
DK1045906T3DenmarkT3
ES2316182T3SpainT3
EP2017341A3European Patent Office (EPO)A3
CA2318029CCanadaC
US2009186812A1United States of AmericaA1
JP2010246560AJapanA
US2011183916A1United States of AmericaA1
CY1108681T1CyprusT1